Research Framework
Measurement → mechanics → prediction → physiological test
Specification of record: Kim (2026), Tissue Mechanics, Afferent Signalling, and Physiological Regulation, https://doi.org/10.5281/zenodo.22149318. This page describes the Labs platform. Where this page and the specification differ, the specification governs.
Rex Autistikōn Labs operates an independent research program on whether measurable mechanical conditions at eight sensor-rich interfaces form a reproducible latent state that predicts physiological outcomes. “Mechanical restriction” is a hypothesis-level construct, not a directly observed scalar.
Current status
- Research architecture established — research question, layered method (measurement → representation → transmission → physiological test), zone taxonomy, falsification criteria (F1–F3), and collaboration governance.
- Measurement protocols under development — zone-specific mechanical acquisition, calibration/QC, and test–retest plans are being defined; they are not yet locked as validated standard operating procedures.
- Computational transmission layer currently illustrative — interactive model and Phase 1 intake parameters (including restriction-like / didactic controls and observational MPA-style scores) explore predicted transmission quantities. They are not empirical tissue measurements.
- Empirical validation pending — reliability of candidate mechanical measures, coherence of any latent “restriction” construct, and preregistered prediction of independent physiological outcomes have not yet been demonstrated.
1. Research question
Why do differences in sensory processing, proprioception, interoception, and related motor–autonomic features often co-occur in some neurodevelopmental presentations, and can part of that covariance be linked to measurable mechanical conditions at defined peripheral interfaces?
Central neural, genetic, and developmental factors are necessary parts of any serious account. The open question is whether independently measurable mechanical states at specific sensor-rich interfaces form a tractable, reproducible contributor to afferent statistics—and whether those states predict physiological outcomes under controlled study.
2. Working hypothesis
Working hypothesis. Chronic differences in local tissue mechanics at specific anatomical zones densely invested with mechanoreceptors and interoceptors can alter the statistics of ascending afferent signals (amplitude, timing). Over time, such altered afferent statistics may contribute to measurable differences in sensory, proprioceptive, and interoceptive regulation.
“Mechanical restriction” names this hypothesized latent mechanical state. It is not treated as a directly observed scalar. Experimental work first characterizes each zone with independently measurable mechanical properties appropriate to its anatomy. Only after measurement and representation layers are specified may a computational transmission model map mechanical representations to predicted afferent-transmission quantities.
This is a mechanistic research hypothesis—not a claim that autism or any neurodevelopmental condition is caused by fascia, reduced to peripheral tissue, or remediated by mechanical intervention. Phenotypes are heterogeneous; peripheral mechanics, if relevant, would be one contributor among many.
Logical chain (explicit)
- Established Mechanoreceptors and interoceptors transduce tissue deformation and internal state into afferent signals.
- Established Soft tissues exhibit viscoelastic and related mechanical behavior; mechanical context can modulate receptor signaling.
- Emerging Selected cranio-cervical, oral, pharyngeal, visceral, and pelvic interfaces are plausible targets given sensory investment and mechanical roles (anatomy-dependent; provisional pending zone dossiers and citations).
- RAL hypothesis Zone-level mechanical state, once measured and represented, systematically relates to altered effective afferent transmission.
- Computational construct Given a mechanical representation, a transmission model can compute predicted quantities (fidelity-like amplitude proxies, precision-weight proxies, free-energy-style costs) for session comparison.
- Open Whether measured mechanical state (and model predictions derived from it) tracks independently collected physiological or behavioral measures.
3. Three distinct layers
The program keeps measurement, mechanical representation, and computational prediction cleanly separated. Confusing them is the main circularity risk we refuse.
1. Measurement layer
Directly observed mechanical quantities obtained with validated or appropriately characterized instruments and protocols (zone-specific).
Not: “restriction,” model output, or MPA-as-mechanics.
2. Mechanical representation layer
Derived parameters such as storage modulus \(G'\), loss modulus \(G''\), strain under standardized loading, hysteresis, relaxation time, tissue displacement/excursion, force–displacement relationships—as applicable and justified per zone.
Not yet: an afferent or physiological prediction.
3. Computational transmission layer
Only after the above: predicted afferent-transmission quantities (fidelity proxies, effective precision proxies, free-energy-style terms, etc.).
Not: a definition of the independent variable.
Causal chain used throughout the program: measurement → mechanical representation → transmission model → predicted physiological consequences → independent physiological test.
4. Operational definition of mechanical restriction
In this program, mechanical restriction is a hypothesis-level construct: a proposed latent mechanical state at a zone that may distort afferent signaling. It is not a primary instrument reading.
- Each zone is first characterized using independently measurable mechanical properties suited to its anatomy.
- Candidate measurements remain distinct at acquisition. They are not assumed interchangeable across instruments or zones.
- Any future composite restriction index must be specified prospectively, including: components, units, normalization, weighting or dimensional-reduction method, missing-data rules, reliability thresholds, zone-specific procedures, and explicit mapping from the index to computational transmission parameters.
- No post-hoc adjustment of the index is permitted on the basis of whether it produces a predicted physiological outcome.
- The computational transmission model must never be used to define restriction retrospectively.
5. Role of MPA and observational scores
MPA (and similar observational scores) are treated initially as independent observational variables. Their reliability and their correspondence with objective mechanical measurements will be evaluated through preregistered analyses.
MPA is not used as the primary determinant of any computational restriction parameter until and unless it demonstrates adequate validity for that purpose. Until then, MPA may appear only in exploratory or secondary analyses, clearly labeled.
6. Evidence matrix
Strength labels are qualitative program judgments for communication, not meta-analytic grades.
| Component | Status | Evidence strength | Role in RAL |
|---|---|---|---|
| Proprioceptive / interoceptive transduction | Established | High | Background science |
| Soft-tissue viscoelasticity / continuum mechanics | Established | High | Measurement & representation substrate |
| Fascial mechanotransduction | Emerging | Moderate | Motivates zone focus |
| Zone-appropriate measurable mechanical properties | Emerging | Variable / methods-dependent | Measurement layer |
| Single latent “restriction” construct across measures | Hypothesis | Limited | To be tested, not assumed |
| Mechanical representation → predicted transmission metrics | RAL construct | Model-defined | Computational layer |
| Mechanical state predicts physiological outcomes | Open | Unknown | Physiological test layer |
| MPA as valid proxy for mechanical state | Open | Unknown | Secondary until validated |
7. Zone taxonomy and zone-specific measurement
Intake and analysis use one consistent eight-zone schema. Labels denote research interfaces, not diagnostic categories. The eight interfaces differ substantially in anatomy: the common element is the analytical framework, not a single physical measurement technique.
Oculomotor–orbital soft tissue and periocular mechanical context.
Middle-ear mechanical environment relevant to auditory coupling.
Nasal airway and associated soft-tissue mechanical context.
Tongue and floor-of-mouth complex.
Pharyngeal–laryngeal soft-tissue interfaces.
Suboccipital muscular–fascial complex and upper cervical context.
Diaphragmatic and visceral fascial mechanical interface.
Pelvic floor and perineal mechanical interface.
Zone dossier requirements
For each zone, documentation must specify:
- Anatomical target
- Measurable mechanical properties (candidates)
- Acquisition method / instrument class
- Calibration and quality-control procedures
- Expected measurement range
- Test–retest requirements
- Permitted transformation into the common computational representation
- Which measurements are unavailable or inappropriate for that zone
Shear-wave elastography, force–displacement protocols, and related methods are candidates where anatomically appropriate—not universal defaults for all eight zones.
8. Computational transmission layer
After a zone’s mechanical state has been measured and mapped into a mechanical representation, a computational transmission model may generate predicted afferent-transmission quantities for research comparison (amplitude/fidelity-like terms, effective precision proxies, free-energy-style costs). Didactic only; not a test of the specification.
Phase 1 status. Current software may accept illustrative parameters (including a didactic restriction-like control and stiffness/viscosity-style terms) so collaborators can inspect model behavior. Those illustrative inputs are not a claim that restriction has been measured in tissue.
- What the model is: a transparent, versioned mapping from a stated mechanical representation to predicted transmission metrics.
- What the model is not: a biomarker, diagnostic classifier, definition of the independent variable, or proof of central pathophysiology.
- Versioning: every calculation stores a
model_versionso later formula changes do not mix silently with historical outputs.
9. How we test it (experimental program)
Phase I — Measurement competence
For each zone: define anatomical target, candidate mechanical observables, acquisition method, calibration/QC, expected ranges, and test–retest plan. Explicitly record what is not measurable for that zone.
Phase II — Mechanical representation
Specify how raw measurements map to a common analytical representation (parameters, units, transforms). Assess reliability and, where multiple measures exist, concordance.
Phase III — Transmission predictions
Apply the computational layer to representations from Phase II. Predictions are outputs, not inputs. Model version identifiers are retained with each run.
Phase IV — Physiological tests
Preregister whether measured mechanical state (and/or prospectively defined composites) predicts independent physiological outcomes (e.g. interoceptive markers, partner-chosen sensory measures). Partner institutions remain responsible for human-subjects compliance.
Phase V — Intervention-linked studies (only if warranted)
Only if earlier phases support mechanistic relevance under preregistered criteria. Designs must be capable of clear failure if effects are absent.
10. Falsification criteria
The restriction construct will be considered unsupported if, under adequate study design:
F1 — Reliability failure
Proposed mechanical measurements for a zone fail to demonstrate adequate reliability (including test–retest criteria set in advance).
F2 — Construct failure
Where a common latent mechanical construct is predicted, different candidate measures show no reproducible relationship.
F3 — Predictive failure
Measured mechanical state fails to predict independently collected physiological outcomes under preregistered analyses.
Internal software checks (sensitivity of computed metrics to illustrative parameter changes) are quality assurance only. They do not establish that restriction exists in tissue, and the computational model must never define restriction retrospectively.
11. Scope and limits
We claim
- A clear research question and mechanistic hypothesis.
- A layered method: measurement → representation → prediction → physiological test.
- Zone-specific measurement dossiers as a requirement of serious work.
- Versioned computational tools and governed collaboration infrastructure.
- Willingness to revise or reject the restriction construct under F1–F3.
We do not claim
- That “restriction” is directly observed as a single scalar.
- That autism or any condition is caused by myofascial restriction alone.
- Diagnostic accuracy or clinical triage use.
- Proven therapeutic efficacy of any intervention.
- That Phase-1 illustrative software parameters equal empirical measurements.
Rex Autistikon Research Foundation, Inc. is a 501(c)(3) public charity (EIN 42-3220323). Determination documentation is available via the Transparency page or upon request.
12. Research platform
- Collaborator access request — reviewed institutional onboarding.
- How to collaborate / handbook materials — protocol expectations.
- Data Intake — Phase-1 pipeline (illustrative parameters labeled as such).
- Results Dashboard — personal history and de-identified collective views; model version stamped.
- Interactive model — didactic transmission layer, not measurement.
- Publications — primary documents, DOI, future methods/data releases.
A skeptical reader should be able to disagree with the hypothesis and still recognize a structured attempt to separate measurement from modeling, to state failure conditions, and to refuse retrospective definition of the independent variable.